• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤进展和转移扩散中的免疫串扰:一场复杂的对话。

Immune crosstalk in cancer progression and metastatic spread: a complex conversation.

机构信息

Division of Tumour Biology & Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.

Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, Netherlands.

出版信息

Nat Rev Immunol. 2020 Aug;20(8):483-497. doi: 10.1038/s41577-019-0271-z. Epub 2020 Feb 5.

DOI:10.1038/s41577-019-0271-z
PMID:32024984
Abstract

Metastatic disease is responsible for approximately 90% of cancer deaths. For successful dissemination and metastasis, cancer cells must evade detection and destruction by the immune system. This process is enabled by factors secreted by the primary tumour that shape both the intratumoural microenvironment and the systemic immune landscape. Here, we review the evidence of aberrant immune cell crosstalk in metastasis formation and the role that primary tumours play in hijacking these interactions in order to enhance their metastatic potential. Moreover, we highlight the intriguing parallels between the inflammatory pathways underlying inflammatory disorders and cancer progression.

摘要

转移性疾病约占癌症死亡人数的 90%。为了成功扩散和转移,癌细胞必须逃避免疫系统的检测和破坏。这一过程是由原发性肿瘤分泌的因子所驱动的,这些因子不仅塑造了肿瘤内的微环境,还塑造了全身的免疫景观。在这里,我们回顾了在转移形成过程中异常免疫细胞串扰的证据,以及原发性肿瘤在劫持这些相互作用以增强其转移潜力方面所起的作用。此外,我们还强调了炎症性疾病和癌症进展背后的炎症途径之间存在的有趣相似之处。

相似文献

1
Immune crosstalk in cancer progression and metastatic spread: a complex conversation.肿瘤进展和转移扩散中的免疫串扰:一场复杂的对话。
Nat Rev Immunol. 2020 Aug;20(8):483-497. doi: 10.1038/s41577-019-0271-z. Epub 2020 Feb 5.
2
Tuning cancer fate: the unremitting role of host immunity.调控癌症转归:宿主免疫的不懈作用
Open Biol. 2017 Apr;7(4). doi: 10.1098/rsob.170006.
3
Regulation of tumor immunity by tumor/dendritic cell fusions.肿瘤/树突状细胞融合对肿瘤免疫的调节
Clin Dev Immunol. 2010;2010:516768. doi: 10.1155/2010/516768. Epub 2010 Oct 26.
4
Mechanism of immune escape of cancer and its regulation.癌症免疫逃逸机制及其调控
Rinsho Ketsueki. 2009 May;50(5):375-80.
5
Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.免疫肿瘤学:了解免疫系统在癌症中的功能和失调。
Ann Oncol. 2012 Sep;23 Suppl 8(Suppl 8):viii6-9. doi: 10.1093/annonc/mds256.
6
IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.IFN-γ 对于细胞毒性 T 细胞依赖的肿瘤基因组免疫编辑是必需的。
Nat Commun. 2017 Feb 24;8:14607. doi: 10.1038/ncomms14607.
7
Cancer metastasis as a non-healing wound.癌症转移如同无法愈合的创伤。
Br J Cancer. 2021 Apr;124(9):1491-1502. doi: 10.1038/s41416-021-01309-w. Epub 2021 Mar 17.
8
Tumor immune escape mechanisms that operate during metastasis.肿瘤转移过程中的免疫逃逸机制。
Curr Pharm Biotechnol. 2011 Nov;12(11):1923-36. doi: 10.2174/138920111798376987.
9
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.肿瘤定位、第二信号和交叉启动在细胞毒性T细胞诱导中的作用。
Nature. 2001 Jun 28;411(6841):1058-64. doi: 10.1038/35082583.
10
Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.免疫细胞衍生的外泌体在癌症免疫周期中的作用
Trends Cancer. 2020 Jun;6(6):506-517. doi: 10.1016/j.trecan.2020.02.013. Epub 2020 Mar 17.

引用本文的文献

1
Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages.乳腺癌亚型和疾病阶段的全身免疫格局综合分析。
Immunooncol Technol. 2025 Jul 29;27:101065. doi: 10.1016/j.iotech.2025.101065. eCollection 2025 Sep.
2
The Prognostic Value of the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Lung Cancer: A Systematic Review and Meta-Analysis.血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分在肺癌中的预后价值:一项系统评价和荟萃分析
J Clin Med. 2025 Aug 12;14(16):5701. doi: 10.3390/jcm14165701.
3
Systematic Analysis of an Immune-Related Gene Signature for Predicting Prognosis and Immune Characteristics in Primary Lower Grade Glioma.

本文引用的文献

1
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.抑癌基因 p53 的缺失会触发 WNT 依赖性全身炎症反应,从而促进乳腺癌转移。
Nature. 2019 Aug;572(7770):538-542. doi: 10.1038/s41586-019-1450-6. Epub 2019 Jul 31.
2
Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species.单细胞转录组学分析人类和小鼠肺癌揭示了个体和物种间保守的髓系细胞群体。
Immunity. 2019 May 21;50(5):1317-1334.e10. doi: 10.1016/j.immuni.2019.03.009. Epub 2019 Apr 9.
3
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response.
用于预测原发性低级别胶质瘤预后和免疫特征的免疫相关基因特征的系统分析
Biomed Res Int. 2025 Aug 12;2025:6180391. doi: 10.1155/bmri/6180391. eCollection 2025.
4
Identification of optimal biomarkers associated with distant metastasis in breast cancer using Boruta and Lasso machine learning algorithms.使用Boruta和套索机器学习算法识别与乳腺癌远处转移相关的最佳生物标志物。
BMC Cancer. 2025 Aug 13;25(1):1311. doi: 10.1186/s12885-025-14664-1.
5
ETS1 Orchestrates a Hybrid EMT Program Driving in vivo Metastasis and Immune Evasion.ETS1 精心编排一种混合上皮-间质转化程序,驱动体内转移和免疫逃逸。
bioRxiv. 2025 Jul 21:2025.07.17.665404. doi: 10.1101/2025.07.17.665404.
6
Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives.利用天然产物克服胃癌耐药性:机制与治疗前景
Int J Biol Sci. 2025 Jul 11;21(10):4604-4628. doi: 10.7150/ijbs.113709. eCollection 2025.
7
Primary and secondary metastatic dissemination: multiple routes to cancer-related death.原发性和继发性转移扩散:癌症相关死亡的多种途径。
Mol Cancer. 2025 Jul 22;24(1):203. doi: 10.1186/s12943-025-02389-5.
8
Tumor-intrinsic ENO1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD-L1 immunotherapy in bladder cancer.肿瘤内在的ENO1抑制促进抗肿瘤免疫反应并提高抗PD-L1免疫疗法在膀胱癌中的疗效。
J Exp Clin Cancer Res. 2025 Jul 15;44(1):207. doi: 10.1186/s13046-025-03464-x.
9
Deep learning-based quantification of tumor-infiltrating lymphocytes as a prognostic indicator in nasopharyngeal carcinoma: multicohort findings.基于深度学习的肿瘤浸润淋巴细胞定量分析作为鼻咽癌预后指标:多队列研究结果
ESMO Open. 2025 Jul 3;10(7):105494. doi: 10.1016/j.esmoop.2025.105494.
10
Advances and challenges in pathomics for liver cancer: From diagnosis to prognostic stratification.肝癌病理组学的进展与挑战:从诊断到预后分层
World J Clin Oncol. 2025 Jun 24;16(6):107646. doi: 10.5306/wjco.v16.i6.107646.
治疗性靶向巨噬细胞可通过释放 I 型干扰素反应增强化疗疗效。
Nat Cell Biol. 2019 Apr;21(4):511-521. doi: 10.1038/s41556-019-0298-1. Epub 2019 Mar 18.
4
Neutrophils escort circulating tumour cells to enable cell cycle progression.中性粒细胞护送循环肿瘤细胞以促进细胞周期进程。
Nature. 2019 Feb;566(7745):553-557. doi: 10.1038/s41586-019-0915-y. Epub 2019 Feb 6.
5
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells.共生菌群通过 γδ T 细胞促进肺癌发生。
Cell. 2019 Feb 21;176(5):998-1013.e16. doi: 10.1016/j.cell.2018.12.040. Epub 2019 Jan 31.
6
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities.转移的免疫调控:机制见解与治疗机会。
Dis Model Mech. 2018 Oct 24;11(10):dmm036236. doi: 10.1242/dmm.036236.
7
Unique pattern of neutrophil migration and function during tumor progression.在肿瘤进展过程中,中性粒细胞迁移和功能呈现独特模式。
Nat Immunol. 2018 Nov;19(11):1236-1247. doi: 10.1038/s41590-018-0229-5. Epub 2018 Oct 15.
8
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.中性粒细胞胞外诱捕网在炎症期间产生,可唤醒小鼠体内休眠的癌细胞。
Science. 2018 Sep 28;361(6409). doi: 10.1126/science.aao4227.
9
Natural killer cells and other innate lymphoid cells in cancer.自然杀伤细胞和癌症中的其他固有淋巴细胞。
Nat Rev Immunol. 2018 Nov;18(11):671-688. doi: 10.1038/s41577-018-0061-z.
10
CD4 T cell help in cancer immunology and immunotherapy.CD4 T 细胞在癌症免疫和免疫治疗中的作用。
Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0.